Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunction-Reference-Cited by-同舟云学术

Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunction

Published:2020-01-09 Issue:8 Volume:22 Page:1402-1411
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Rossignol Patrick¹,Duarte Kevin¹,Girerd Nicolas¹,Karoui Moez¹,McMurray John J.V.²,Swedberg Karl³,Veldhuisen Dirk J.⁴,Pocock Stuart⁵,Dickstein Kenneth⁶,Zannad Faiez¹,Pitt Bertram⁷

Affiliation:

1. Université de Lorraine, Inserm, Centre d'Investigations Cliniques‐ Plurithématique 14‐33, and Inserm U1116, CHRU de Nancy, F‐CRIN INI‐CRCT (Cardiovascular and Renal Clinical Trialists) Nancy France

2. The British Heart Foundation Cardiovascular Research Centre University of Glasgow Glasgow UK

3. Sahlgrenska Academy University of Gothenburg Gothenburg Sweden

4. University of Groningen, University Medical Center Groningen Groningen The Netherlands

5. Department of Biostatistics London School of Hygiene & Tropical Medicine London UK

6. Department of Cardiology University of Bergen, Stavanger University Hospital Stavanger Norway

7. University of Michigan School of Medicine Ann Arbor MI USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.1724

Reference33 articles.

1. Short‐term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data;Krogager ML;Eur Heart J,2017

2. Short-term mortality risk of serum potassium levels in acute heart failure following myocardial infarction

3. Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications

4. Associations of serum potassium levels with mortality in chronic heart failure patients

5. Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Logistic analysis of delayed reporting of emergency blood potassium and comparison of improved outcomes;Scientific Reports;2024-03-13

2. Medical Treatment in Heart Failure with Reduced Ejection Fraction: A Proposed Algorithm Based on the Patient’s Electrolytes and Congestion Status;Medical Sciences;2023-05-24

3. Egyptian Consensus on Hyperkalemia Management: Lessons from Recent Evidences;International Journal of Clinical Medicine;2023

4. Heart failure: an update from the last years and a look at the near future;ESC Heart Failure;2022-12

5. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial;European Heart Journal;2022-08-23